Kestra Advisory Services’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.69K Hold
356
﹤0.01% 3256
2026
Q1
$9.36K Buy
356
+156
+78% +$19.6K ﹤0.01% 3106
2025
Q4
$49.6K Hold
200
﹤0.01% 3941
2025
Q3
$42.1K Buy
+200
New +$35.3K ﹤0.01% 2868

Other funds holding GOSS

Kestra Advisory Services's GOSS Position: Q2 2026 in Review

Kestra Advisory Services held its Gossamer Bio (GOSS) position steady in Q2 2026 at 356 shares worth $4.69K. The position accounts for ﹤0.01% of the portfolio, ranked #3256.

Kestra Advisory Services first reported a position in GOSS in Q3 2025 and has held it in 4 quarters since. The position peaked at $49.6K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Kestra Advisory Services held 356 shares of Gossamer Bio worth $4.69K as of Q2 2026.
  • Kestra Advisory Services left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #3256 holding.
  • Kestra Advisory Services first reported a position in Gossamer Bio in Q3 2025 and has held it in 4 quarters since.
  • Kestra Advisory Services's Gossamer Bio position peaked at $49.6K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.